RAINBOW₹1,462.00

Rainbow Childrens Medicare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISKIMSPOLYMEDPFIZERONESOURCEJUBLPHARMAVIJAYAMcap ₹14,848 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity17.1616.5016.7316.73
Return on Assets10.0610.2710.1510.15
Return on Capital Employed15.6815.7915.1915.19
Return on Invested Capital24.7629.4225.2526.62
Margins
EBITDA Margin33.0732.3231.9531.60
Operating Margin24.4323.1823.1123.11
Incremental Operating Margin—15.8222.51—
Pretax Margin22.7321.7721.0320.37
Net Income Margin16.8316.1116.5315.95
Net Income to Common Margin16.7316.0616.3415.68
FCF Margin-2.4816.4911.9311.93
Additional
Effective Tax Rate25.9625.9921.4121.72
Dvd Payout Ratio14.0912.4710.82—
Sustainable Growth Rate14.7414.4414.9216.73
Incremental Operating Margin %15.8222.5119.66—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.